|
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers |
1.30 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Current Topics in Management of Non-Muscle Invasive Bladder Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Debate - What is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia: Chemoimmunotherapy or Small Molecule Inhibitor Therapy? |
1.25 |
05/18/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Emerging Treatment Options for the Management of Metastatic Colorectal Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Evidence-Based Approaches to Smoking Cessation in Patients with Cancer |
1.30 |
06/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Evolution of Immunotherapy and Management of Complex Toxicities |
1.00 |
05/20/2020 - 12:00am to 05/20/2021 - 12:00am |
|
Expert Insights on New Systemic Therapies for Advanced Prostate Cancer |
1.50 |
06/05/2019 - 10:00am to 06/05/2020 - 12:00am |
|
Genetics/Familial Risk Assessment for Breast Cancer: Controversies and Evolving Principles |
0.60 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Immune Checkpoint Inhibitor Toxicities |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Immunotherapies in Non-Small Cell Lung Cancer |
1.25 |
12/17/2019 - 12:00am to 12/17/2020 - 12:00am |
|
Implementing Clinical Trials in the Community Setting |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Is There a Role for Proton Therapy in the Treatment of Breast Cancer? |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Key Considerations in Adopting a Value-Based Payment Model |
1.30 |
06/05/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Locoregional Management of Early-Stage Breast Cancer |
0.75 |
05/21/2020 - 12:00am to 03/01/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward